Scarica l'app Stockscreener
8.07
1.34%
-0.11
Dopo l'orario di chiusura:
8.06
-0.010
-0.12%
Precedente Chiudi:
$8.18
Aprire:
$8.27
Volume 24 ore:
188.80K
Relative Volume:
0.15
Capitalizzazione di mercato:
$539.66M
Reddito:
-
Utile/perdita netta:
$-103.21M
Rapporto P/E:
-1.7543
EPS:
-4.6001
Flusso di cassa netto:
$-26.70M
1 W Prestazione:
+0.00%
1M Prestazione:
+27.29%
6M Prestazione:
+122.93%
1 anno Prestazione:
-6.60%
Intervallo 1D:
$7.84
$8.27
Intervallo di 1 settimana:
$7.5519
$8.285
Portata 52W:
$2.65
$11.14
Engene Holdings Inc Stock (ENGN) Company Profile
Nome
Engene Holdings Inc
Settore
Industria
Telefono
(514) 332-4888
Indirizzo
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Confronta ENGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
8.07 | 549.69M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | Iniziato | Piper Sandler | Overweight |
| 2025-02-14 | Downgrade | UBS | Buy → Neutral |
| 2024-12-23 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-27 | Iniziato | Raymond James | Outperform |
| 2024-11-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-08-28 | Iniziato | Oppenheimer | Outperform |
| 2024-04-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-15 | Iniziato | Guggenheim | Buy |
| 2024-03-28 | Iniziato | UBS | Buy |
| 2024-03-08 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-20 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Engene Holdings Inc Borsa (ENGN) Ultime notizie
enGene Holdings Inc (ENGN) Surging After Positive Phase 2 LEGEND Trial - Finviz
How enGene Holdings Inc. stock performs in rate cut cyclesJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program - Investing.com Nigeria
Franklin Resources Inc. Sells 136,866 Shares of enGene Holdings Inc. $ENGN - MarketBeat
9 Best Up and Coming Canadian Stocks to Buy - Insider Monkey
FDA selects enGene’s bladder cancer therapy for development program By Investing.com - Investing.com Australia
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readines - pharmiweb.com
enGene stock rises after FDA selects bladder cancer therapy for CMC pilot program - Investing.com Nigeria
Engene's detalimogene selected for FDA manufacturing pilot program to support manufacturing readiness - marketscreener.com
enGene’s Detalimogene Chosen for FDA Manufacturing Pilot Program - TipRanks
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness - Markets Financial Content
What valuation multiples suggest for enGene Holdings Inc. Equity Warrant stockEarnings Performance Report & Risk Managed Investment Entry Signals - Newser
Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsForecast Cut & AI Optimized Trading Strategy Guides - moha.gov.vn
enGene Holdings Inc Stock Analysis and ForecastHealthcare Stock Analysis & Learn the Secrets of Pro Traders - earlytimes.in
enGene (NASDAQ:ENGN) Trading Up 6.9%Should You Buy? - MarketBeat
enGene Holdings Prices $130 Million Public Offering to Advance Genetic Medicine Programs - MSN
enGene to Present at Piper Sandler Healthcare Conference - TipRanks
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference - Markets Financial Content
PERCEPTIVE ADVISORS LLC's Strategic Acquisition in enGene Holdings Inc. - GuruFocus
What drives enGene Holdings Inc Equity Warrant stock priceDebt-to-Equity Ratio Analysis & High Return Trading Ideas - earlytimes.in
enGene Holdings Inc. (ENGN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is enGene Holdings Inc. stock a dividend growth opportunityBuy Signal & Momentum Based Trading Ideas - newser.com
How enGene Holdings Inc. Equity Warrant stock reacts to inflationary pressuresTrade Performance Summary & Growth Focused Entry Point Reports - newser.com
How enGene Holdings Inc. stock compares to growth peersGap Down & Stock Timing and Entry Methods - newser.com
enGene Holdings Inc. (S0N.F) stock price, news, quote and history - Yahoo Finance UK
Is a relief rally coming for enGene Holdings Inc. holders2025 Institutional Moves & Weekly High Return Stock Forecasts - newser.com
Is enGene Holdings Inc. Equity Warrant trending in predictive chart modelsPortfolio Update Report & Breakout Confirmation Trade Signals - newser.com
Is enGene Holdings Inc. Equity Warrant stock bottoming out2025 Top Decliners & Daily Entry Point Alerts - newser.com
Multi asset correlation models including enGene Holdings Inc. Equity WarrantWeekly Trade Recap & Verified Momentum Watchlists - newser.com
How institutional buying supports enGene Holdings Inc. stockQuarterly Investment Review & Safe Entry Trade Reports - newser.com
ENGN: Non-viral gene therapy for NMIBC achieves 62% six-month CR rate, targeting 2027 approval - TradingView
Is enGene Holdings Inc. Equity Warrant stock undervalued vs historical averages2025 Price Targets & Weekly High Return Opportunities - newser.com
enGene Holdings (ENGN) Price Target Increased by 10.59% to 24.20 - Nasdaq
Will enGene Holdings Inc. stock reach all time highs in 2025July 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
Has enGene Holdings Inc. Equity Warrant found a price floorSwing Trade & Community Verified Trade Alerts - newser.com
Engene Holdings Inc Azioni (ENGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.44%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):